35 patents currently held
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jul 2036. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jul 2036
Next term end
2
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends Jul 2036 · High confidence
Also notable
Ends Feb 2041 · High confidence
Systems and Methods for Phototherapeutic Modulation of Nitric Oxide
US 11,617,895
Cited by 26 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2036.
Nitric Oxide-Releasing Antibacterial Compounds, Formulations, and Methods Pertaining Thereto
US 11,813,270
Granted 2023. Computed term ends 2041.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 27, 2026The maintenance fee for Illumination Devices for Inducing Biological Effects (US 11,684,798) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
- 1 fee due Mar 12, 2027The maintenance fee for Illumination Devices for Inducing Biological Effects (US 11,752,359) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
- 1 fee due May 14, 2027The maintenance fee for Nitric Oxide-Releasing Antibacterial Compounds, Formulations, and Methods Pertaining Thereto (US 11,813,270) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
- 1 fee due Jul 7, 2027The maintenance fee for Systems and Methods for Phototherapeutic Modulation of Nitric Oxide (US 10,525,275) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.
- 1 fee due Aug 25, 2027The maintenance fee for Systems and Methods for Phototherapeutic Modulation of Nitric Oxide (US 10,569,097) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
- 1 fee due Nov 7, 2027The maintenance fee for Devices and Related Methods for Phototherapeutic Treatment of Skin (US 11,975,215) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Systems and Methods for Phototherapeutic Modulation of Nitric Oxide | 33 in force | to Feb 2044 |
| Nitric Oxide-Releasing Antibacterial Compounds, Formulations, and Methods Pertaining Thereto | 2 in force | to Feb 2041 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,524,173 | Systems and Methods for Phototherapeutic Modulation of Nitric Oxide In force · High confidence | In force | High confidence | |
| US 11,617,895 | Systems and Methods for Phototherapeutic Modulation of Nitric Oxide In force · High confidence | In force | High confidence | |
| US 12,397,169 | Phototherapeutic Light for Treatment of Pathogens In force · Medium confidence | In force | Medium confidence | |
| US 12,427,333 | Phototherapy Devices for Treatment of Dermatological Disorders of the Scalp In force · High confidence | In force | High confidence | |
| US 12,440,697 | Systems and Methods for Phototherapeutic Modulation of Nitric Oxide In force · High confidence | In force | High confidence | |
| US 12,551,716 | Phototherapy Devices for Treatment of Dermatological Disorders of the Scalp In force · Medium confidence | In force | Medium confidence | |
| US 12,691,298 | Phototherapy Devices for Treatment of Dermatological Disorders of the Scalp In force · Medium confidence | In force | Medium confidence | |
| US 11,400,309 | Phototherapy Devices for Treatment of Dermatological Disorders of the Scalp In force · High confidence | In force | High confidence | |
| US 12,179,035 | Phototherapeutic Light for Treatment of Pathogens In force · Medium confidence | In force | Medium confidence | |
| US D952,171 | Oral Illumination Device In force · High confidence | In force | High confidence |
Also on record, not counted in the 35: 1 patent in force now held by others · 19 applications pending · 5 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
2 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed